IRIS
MONTELEONE, IVAN SALVATORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.410
AS - Asia 3.319
EU - Europa 3.027
SA - Sud America 535
Continente sconosciuto - Info sul continente non disponibili 434
AF - Africa 74
OC - Oceania 12
Totale 33.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.142
SG - Singapore 1.532
CN - Cina 704
IT - Italia 625
BR - Brasile 436
DE - Germania 428
RU - Federazione Russa 349
UA - Ucraina 294
HK - Hong Kong 288
VN - Vietnam 239
IE - Irlanda 230
FR - Francia 206
SE - Svezia 187
BD - Bangladesh 182
PL - Polonia 177
GB - Regno Unito 171
FI - Finlandia 165
CA - Canada 111
KR - Corea 77
JP - Giappone 72
IN - India 53
NL - Olanda 50
MX - Messico 39
AR - Argentina 32
BE - Belgio 30
ZA - Sudafrica 25
HN - Honduras 24
AT - Austria 22
IQ - Iraq 22
ID - Indonesia 19
TR - Turchia 19
CO - Colombia 18
CR - Costa Rica 16
SV - El Salvador 16
ES - Italia 14
EC - Ecuador 13
JM - Giamaica 12
TT - Trinidad e Tobago 12
AU - Australia 11
CL - Cile 11
LT - Lituania 11
PK - Pakistan 11
UZ - Uzbekistan 11
EG - Egitto 10
IR - Iran 9
MA - Marocco 9
SC - Seychelles 9
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
PH - Filippine 8
PY - Paraguay 8
RO - Romania 8
VE - Venezuela 8
IL - Israele 7
KZ - Kazakistan 7
TN - Tunisia 7
DK - Danimarca 6
GT - Guatemala 6
JO - Giordania 6
KG - Kirghizistan 6
MY - Malesia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
KE - Kenya 5
A1 - Anonimo 4
AL - Albania 4
AZ - Azerbaigian 4
GP - Guadalupe 4
NI - Nicaragua 4
NO - Norvegia 4
NP - Nepal 4
PR - Porto Rico 4
PT - Portogallo 4
SI - Slovenia 4
BB - Barbados 3
BG - Bulgaria 3
DZ - Algeria 3
GY - Guiana 3
HT - Haiti 3
LB - Libano 3
LK - Sri Lanka 3
MK - Macedonia 3
OM - Oman 3
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
LU - Lussemburgo 2
LV - Lettonia 2
MC - Monaco 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
BH - Bahrain 1
Totale 33.367
Salva come PNG Salva come JPEG
Città #
Woodbridge 6.580
Houston 5.744
Wilmington 5.525
Ashburn 870
Singapore 869
Fairfield 811
Ann Arbor 724
Chandler 444
San Jose 439
Seattle 343
Hong Kong 282
Beijing 276
Cambridge 272
Jacksonville 252
Council Bluffs 251
Rome 231
Dublin 208
Santa Clara 206
New York 166
Medford 156
Kraków 154
Dearborn 149
Los Angeles 137
The Dalles 132
Helsinki 93
Dallas 84
Buffalo 74
Lawrence 73
Hanoi 68
Ho Chi Minh City 67
North Bergen 66
Tokyo 63
Chicago 53
Moscow 49
Boardman 47
San Diego 47
Zhengzhou 47
Lauterbourg 45
São Paulo 40
Milan 39
Menlo Park 34
Orem 34
Denver 33
Montreal 33
Munich 33
Colorado Springs 32
Brooklyn 31
Mülheim 31
Brussels 30
North Charleston 30
London 29
Monte Vista 27
Phoenix 25
Shanghai 24
Frankfurt am Main 23
Indianapolis 23
Nuremberg 23
Atlanta 22
Rio de Janeiro 22
Toronto 22
Warsaw 22
Naples 21
Chennai 17
Philadelphia 17
Redondo Beach 17
Johannesburg 16
San Francisco 16
Jakarta 15
North Hollywood 15
Belo Horizonte 14
Palo Alto 14
Redwood City 14
Seoul 14
Boston 13
Columbus 13
Lappeenranta 13
Miami 13
Mountain View 13
Norwalk 13
Mexico City 12
New Orleans 12
San Salvador 12
Vienna 12
Amsterdam 11
Groningen 11
Guangzhou 11
Mumbai 11
Washington 11
Falls Church 10
Hefei 10
Las Vegas 10
Nanjing 10
University Park 10
Verona 10
Brasília 9
Charlotte 9
Dhaka 9
Kingston 9
Nürnberg 9
San José 9
Totale 27.244
Salva come PNG Salva come JPEG
Nome #
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 624
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 608
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction 607
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 588
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 572
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 566
Aryl hydrocarbon receptor and colitis 554
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 538
Interleukin-34 sustains inflammatory pathways in the gut 533
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 515
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 513
Characterization of IL-17A-producing cells in celiac disease mucosa 513
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 507
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 507
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 499
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 494
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 490
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 485
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 484
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 482
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease 481
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 480
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 479
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 476
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation 475
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis 474
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 474
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 473
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) 470
Enhanced expression of the Fas pathway inhibitor, Flip, in the mucosa of patients with Crohn's disease 463
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 462
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 461
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 458
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 457
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis 452
IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism 448
Inhibition of Smad7 With a Specific Antisense Oligonucleotide Facilitates TGF-β1-Mediated Suppression of Colitis 447
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 447
Defective expression of scavenger receptors in celiac disease mucosa 447
null 442
Th17-related cytokines in inflammatory bowel diseases: friends or foes? 440
Tissue Inhibitor of Metalloproteinase-3 Regulates Inflammation in Human and Mouse Intestine. 437
IL-15 positively regulates IL-21 production in celiac disease mucosa 437
Cytoskeletal proteins and resident flora 435
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 434
Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease 430
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 427
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 426
Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation 407
Th17-related cytokines: new players in the control of chronic intestinal inflammation 403
A functional role for Smad7 in sustaining colon cancer cell growth and survival 401
Interleukin-21 enhances T-helper cell type 1 signaling and interferon-gamma production in Crohn's disease 398
Smad7 positively regulates keratinocyte proliferation in psoriasis 394
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 393
Th17-cytokine blockers as a new approach for treating inflammatory bowel disease 391
Regulation of homeostasis and inflammation in the intestine 386
Metastatic Crohn's disease of the forehead 383
null 377
Interleukin-23 and Th17 cells in the control of gut inflammation 375
Cadherin-11 is a Regulator of Intestinal Fibrosis 354
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 345
Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease 336
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 330
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 290
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 282
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 245
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 242
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 225
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 225
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 215
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 198
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 165
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 164
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 156
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 146
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 125
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 125
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 121
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis 115
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 114
Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa 109
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut 103
Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation 101
Hepatitis B and C virus infection in Crohn's disease 98
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 96
Genetic and pathogenic insights into inflammatory bowel disease 90
Review article: Monitoring the activity of Crohn's disease 89
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn{'}s disease 88
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 78
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 75
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation 74
Resident bacterial flora and immune system 71
High Smad7 marks inflammation in patients with chronic pouchitis 61
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice 58
Smad7 is a negative regulator of immunogenic cell death in colorectal cancer 48
IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function 47
Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells 46
Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA 45
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation 39
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 38
Totale 33.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022634 0 0 0 0 24 92 39 32 87 87 73 200
2022/20231.116 91 114 13 152 107 231 90 74 89 65 74 16
2023/2024408 45 17 17 12 44 82 30 51 7 3 15 85
2024/20252.645 103 492 288 192 73 258 189 105 291 226 246 182
2025/20264.394 344 177 429 381 395 172 513 425 480 462 379 237
2026/20272.029 323 273 792 636 5 0 0 0 0 0 0 0
Totale 33.811